title: Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.
abstract: It was previously demonstrated that insulins to which positive charge has been added by substituting B13 glutamic acid with a glutamine residue, B27 threonine with an arginine or lysine residue, and by blocking the C-terminal carboxyl group of the B-chain by amidation, featured a prolonged absorption from the subcutis of rabbits and pigs after injection in solution at acidic pH. The phenomenon is ascribed to a low solubility combined with the readiness by which these analogs crystallize as the injectant is being neutralized in the tissue. However, acid solutions of insulin are chemically unstable as A21 asparagine both deamidates to aspartic acid and takes part in formation of covalent dimers via alpha-amino groups of other molecules. In order to circumvent the instability, substitutions were introduced in position A21, in addition to those in B13, B27 and B30, challenging the fact that A21 asparagine has been conserved in this position throughout the evolution. Biological potency was retained when glycine, serine, threonine, aspartic acid, histidine and arginine were introduced in this position, although to a varying degree. In the crystal structure of insulin a hydrogen bond bridges the alpha-nitrogen of A21 with the backbone carbonyl of B23 glycine. In order to investigate the importance of this hydrogen bond for biological activity a gene for the single-chain precursor B-chain(1-29)-Ala-Ala-Lys-A-chain(1-21) featuring an A21 proline was synthesized. However, this single-chain precursor failed to be properly produced by yeast, pointing to the formation of this hydrogen bond as an essential step in the folding process. The stability of the A21-substituted analogs in acid solutions (pH 3-4) with respect to deamidation and formation of dimers was approximately 5-10 times higher than that of human insulin in neutral solution. The rate of absorption of most insulins is decreased by increasing the Zn2+ concentration of the preparation. However, one analog with A21 glycine showed first-order absorption kinetics in pigs with a half-life of approximately 25 h, independent of the Zn2+ concentration. The day-to-day variation of the absorption of this analog was significantly lower than that of the conventional insulin suspensions, a property that might render such an insulin useful in the attempts to improve glucose control in diabetics by a more predictable delivery of basal insulin.
authors.affiliation: Novo Research Institute, Bagsvaerd, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Markussen
authors.forename: I
authors.initials: I
authors.lastname: Diers
authors.forename: P
authors.initials: P
authors.lastname: Hougaard
authors.forename: L
authors.initials: L
authors.lastname: Langkjaer
authors.forename: K
authors.initials: K
authors.lastname: Norris
authors.forename: L
authors.initials: L
authors.lastname: Snel
authors.forename: A R
authors.initials: AR
authors.lastname: Sørensen
authors.forename: E
authors.initials: E
authors.lastname: Sørensen
authors.forename: H O
authors.initials: HO
authors.lastname: Voigt
mesh_terms: D000042:Absorption; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D002384:Catalysis; D003460:Crystallization; D004355:Drug Stability; D006801:Humans; D006860:Hydrogen Bonding; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000031:analogs & derivatives* / Q000235:genetics / Q000493:pharmacokinetics / Q000494:pharmacology; D051379:Mice; D009154:Mutation; D010957:Plasmids; D011487:Protein Conformation; D011498:Protein Precursors / Q000096:biosynthesis / Q000235:genetics; D011817:Rabbits; D011994:Recombinant Proteins / Q000096:biosynthesis; D012441:Saccharomyces cerevisiae / Q000235:genetics; D012995:Solubility; D013329:Structure-Activity Relationship; D013552:Swine; D015032:Zinc / Q000493:pharmacokinetics
chemical_list: D000596:Amino Acids; D007328:Insulin; D011498:Protein Precursors; D011994:Recombinant Proteins; D015032:Zinc